Disruptive Pharma AB
Pharmaceutical ManufacturingView the employees at
Disruptive Pharma AB-
Natasha Bank Experienced Business and Marketing Manager | Transforming Pharma & Recruitment | Spreading Positivity 🌟Disruptive Pharma & QRIOS
-
Stockholm, Stockholm County, Sweden
-
Top 5%
Tobias Assander (Lindholm) Head of Process Development & Supply på Disruptive Pharma AB-
Greater Stockholm Metropolitan Area
-
Rising Star
Emilia Klaussén Research Engineer på Disruptive Pharma AB-
Greater Uppsala Metropolitan Area
-
Top 10%
Maryia Borys Analytical Chemist at Disruptive Pharma AB-
Uppsala, Uppsala County, Sweden
-
Rising Star
Hans Thor Senior analytisk kemist på Disruptive Pharma-
Uppsala, Uppsala County, Sweden
-
Rising Star
Overview
Disruptive Pharma is a pharmaceutical company that develops novel drug products by applying a unique drug delivery technology. We develop selected drug products based on our proprietary drug delivery platform, the pharma-grade mesoporous magnesium carbonate (Pharma-MMC). The Disruptive Pharma company has offices in both Uppsala (HQ) and Stockholm. By a clever combination of already approved active pharmaceutical ingredients (APIs) with Pharma-MMC platform, several unique opportunities to realize highly valuable therapeutically equivalent or improved drug products emerges. The Pharma-MMC drug delivery technology can be used to create amorphous solid dispersions of the drug, hence increasing its dissolution and the body’s ability to absorb the drug, and may be used to rescue particularly difficult drugs or to enable novel product formulations Disruptive Pharma is a spin-out from the company Disruptive Materials that is located in Uppsala. The company is well-positioned to exploit its pioneering discovery of a unique mesoporous magnesium carbonate (MMC) material. Up until breakthrough discovery by the group of Professor Maria Strømme in 2012, commercialized by Disruptive Materials AB in 2013.
-